Anne Doering
Direttore Finanziario/CFO presso VIVORYON THERAPEUTICS N.V.
Patrimonio netto: - $ in data 31/05/2024
Profilo
Anne Marie Doering is currently the Chief Financial Officer & Executive Director at Vivoryon Therapeutics NV.
She previously worked as the Director-Investor Relation at BioNTech SE, Director-Group Strategy at Merck KGaA, and Investment Manager at Creathor Venture Management GmbH.
From 2010 to 2019, she served as a Portfolio Manager & Research Analyst at Franklin Templeton Investment Management Ltd.
(Germany).
Ms. Doering holds a graduate degree from the University of Pennsylvania, a graduate degree from the Joseph H Lauder Institute of Management & International, and an MBA from The Wharton School of the University of Pennsylvania.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 06/06/2024 | 0 ( -.--% ) | - $ | 31/05/2024 |
Posizioni attive di Anne Doering
| Società | Posizione | Inizio |
|---|---|---|
| VIVORYON THERAPEUTICS N.V. | Direttore Finanziario/CFO | 01/03/2024 |
Precedenti posizioni note di Anne Doering
| Società | Posizione | Fine |
|---|---|---|
Franklin Templeton Investment Management Ltd. (Germany)
 Franklin Templeton Investment Management Ltd. (Germany) Investment ManagersFinance Franklin Templeton Investment Management Ltd. (Germany) (FTIML-Germany) is the German investment management division of Great Britain-based Franklin Templeton Investment Management Ltd., ultimately owned by Franklin Resources, Inc. (NYSE: BEN) in the US. Headquartered in Frankfurt, the firm was founded in 1992 and manages the Franklin Templeton Investments fund range for individuals, pension funds, trusts, local authorities, corporations, government bodies, fund of funds and multi-managers. | Analyst-Equity | 01/01/2019 |
Creathor Venture Management GmbH
 Creathor Venture Management GmbH Investment ManagersFinance Creathor Venture Management GmbH is an independent private equity firm specialized in technology venture capital investing. Creathor was foundedi n 2003 and is headquartered in Bad Homburg near Frankfurt in central Germany. The management invests their own capital, and manages venture capital funds on behalf of institutions. | Investitore di Private Equity | 01/11/2010 |
| MERCK KGAA | Corporate Officer/Principal | - |
| BIONTECH SE | Contatto Relazioni con gli Investitori | - |
Formazione di Anne Doering
| The Wharton School of the University of Pennsylvania | Masters Business Admin |
| Joseph H Lauder Institute of Management & International | Graduate Degree |
| University of Pennsylvania | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 3 |
|---|---|
| VIVORYON THERAPEUTICS N.V. | Health Technology |
| BIONTECH SE | Health Technology |
| MERCK KGAA | Health Technology |
| Aziende private | 2 |
|---|---|
Creathor Venture Management GmbH
Creathor Venture Management GmbH Investment ManagersFinance Creathor Venture Management GmbH is an independent private equity firm specialized in technology venture capital investing. Creathor was foundedi n 2003 and is headquartered in Bad Homburg near Frankfurt in central Germany. The management invests their own capital, and manages venture capital funds on behalf of institutions. | Finance |
Franklin Templeton Investment Management Ltd. (Germany)
Franklin Templeton Investment Management Ltd. (Germany) Investment ManagersFinance Franklin Templeton Investment Management Ltd. (Germany) (FTIML-Germany) is the German investment management division of Great Britain-based Franklin Templeton Investment Management Ltd., ultimately owned by Franklin Resources, Inc. (NYSE: BEN) in the US. Headquartered in Frankfurt, the firm was founded in 1992 and manages the Franklin Templeton Investments fund range for individuals, pension funds, trusts, local authorities, corporations, government bodies, fund of funds and multi-managers. | Finance |
- Borsa valori
- Insiders
- Anne Doering
